Introduction Research evidence has shown that catheter ablation is a safe and superior
treatment for atrial fibrillation (AF) compared to medical therapy, but real‐world practice has …

Catheter ablation is a potentially cost-effective strategy in select patients with atrial
fibrillation. Long-term randomized studies that compare it to conventional care and focus on …

Objectives Assessing the cost-effectiveness credentials of this intervention in patients with
concomitant atrial fibrillation (AF) and heart failure (HF) compared with usual medical …

Atrial fibrillation (AF) is the most common clinically important cardiac arrhythmia. It is an
important cause of stroke, contributes to the burden of heart failure and is a major contributor …

Atrial fibrillation (AF) is estimated to affect 1%–2% of the population. It is increasing in
prevalence and is associated with excess mortality, considerable morbidity and …

Aim To assess the outcome and cost of catheter ablation of atrial fibrillation (AF) in Belgium.
Methods and results From a nationwide health insurers' database, we retrieved claims data …

Introduction: There is emerging evidence for clinical superiority of catheter ablation over rate
and rhythm control strategies in paroxysmal atrial fibrillation (PAF). The objective of this …

Background Catheter ablation (CA) is superior to antiarrhythmic therapy at reducing
recurrence of atrial fibrillation (AF); however, there are limited data regarding whether this …

Background: Despite the publication of several randomized clinical trials comparing catheter
ablation (CA) with medical therapy (MT) in patients with atrial fibrillation (AF), the superiority …

Background It is still controversial whether catheter ablation for atrial fibrillation (AF)
improves survival and other outcomes in patients with AF. This study evaluated whether …